Insider · CIK 0001480371
David R. Wells
Files at HSCS (Heart Test Laboratories, Inc.), COCH (Envoy Medical, Inc.). First filing -, latest -.
In brief
David R. Wells files SEC Form 4 as director and CFO at HSCS (Heart Test Laboratories, Inc.), and also at COCH (Envoy Medical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David R. Wells has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | HSCS Heart Test Laboratories, Inc. | AGrant or award Restricted Stock Unitsderivative | +15,000 | $0.00 | $0 | 15,000 | Jan 12, 2026 |
| Jul 9, 2025 | HSCS Heart Test Laboratories, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | - | - | 25,000 | Jul 11, 2025 |
| Jan 16, 2025 | HSCS Heart Test Laboratories, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,000 | - | - | 6,000 | Jan 21, 2025 |
| Oct 15, 2023 | COCH Envoy Medical, Inc. | AGrant or award Stock Option (right to buy)derivative | +293,250 | $0.00 | $0 | 293,250 | Oct 17, 2023 |
Questions about David R. Wells
Answered from the filings on this page, as of the latest one.
Is David R. Wells buying or selling?
David R. Wells has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David R. Wells's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David R. Wells has 0.
Where does David R. Wells file Form 4?
David R. Wells has filed Form 4 at HSCS (Heart Test Laboratories, Inc.); COCH (Envoy Medical, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.